The PQA Quality Forum Webinar is a regular, recurring series on healthcare quality topics with a focus on medication use and medication services. It is a forum for educating and engaging with PQA members and quality-focused healthcare professionals.
Prescription opioid-related deaths are one of the leading preventable public health problems. High-risk prescribing practices have contributed to the opioid overdose epidemic. These include overlapping opioid and benzodiazepine prescriptions, prescribing high-dose opioids and using multiple prescribers or pharmacies for opioid prescriptions.
The PQA Quality Forum Webinar is a recurring series on healthcare quality topics which focus on medication use and medication services. The quality forum creates an opportunity for education and engagement with PQA members and quality-focused healthcare professionals.
PQA members are currently voting on three measures up for endorsement and two up for retirement.
PQA’s Board of Directors represents a diverse group of thought leaders and experts in healthcare, who understand how medication optimization improves patient outcomes and supports a value-based care system. Their expertise helps PQA advance the safe and appropriate use of medicines. This blog is one in a series profiling PQA's Board members.
The Pharmacy Quality Alliance (PQA) has developed a 3-hour online continuing education (CE) course on “Measuring Quality to Improve HIV Medication Use.” Launched September 8, the course complements CE and training programs that are focused on clinical practice.
PQA is a non-profit organization with 250 diverse members across healthcare. Our members include community and specialty pharmacy organizations, pharmacists and other healthcare providers, pharmacies, health plans, pharmacy benefit managers, life sciences, technology vendors, government agencies, health information technology partners, researchers, accrediting organizations and academia.
PQA’s Board of Directors represents a diverse group of thought leaders and experts in healthcare, who understand how medication optimization improves patient outcomes and supports a value-based care system. Their expertise helps PQA advance the safe and appropriate use of medicines. This blog is one in a series profiling PQA's Board members.
Human immunodeficiency virus (HIV) is a complex disease, and its prevention and treatment have progressed through scientific discoveries, clinical training, continuing education, and widespread public health campaigns. However, gaps in knowledge and practice remain, related to quality improvement and especially to medication use.
The Pharmacy Quality Alliance (PQA) continues to forge ahead with our work to develop a set of standard pharmacy performance measures that would be appropriate for use in value-based plan-pharmacy agreements. Over the past 3 years, we have convened and worked with a broad base of industry leaders to identify and vet pharmacy performance measures that meet the needs of pharmacies, payers, and patients—while balancing feasibility and probability for success.
Concepts Could Be Used in Payer-Pharmacy Value-Based Arrangements
One week ago today, PQA members gathered in person for the first time in two years for the 2021 PQA Leadership Summit. The energy, enthusiasm and engagement across this two-day meeting was incredible. It was my first PQA Leadership Summit, and the event reaffirmed my belief that PQA is unique in its collaborative spirit.
PQA offers a variety of student and post-graduate programs, including experiential rotations, internships and fellowships. Each is focused on providing healthcare quality experience to diverse individuals from diverse disciplines.
PQA follows a systematic, transparent and consensus-based development process to ensure that measures are important, scientifically acceptable, feasible and usable. This approach produces strong, consistent results, but it also takes time.
The fourth quarter every year is a busy time in PQA's measure development work. We're often nearing completion of new measures and planning for the next year, which includes creating or renewing development panels and finalizing the next edition of the PQA Measure Manual
Collaboration is one of PQA's greatest attributes, and our measure development process is a prime example of how our diverse member organizations reach consensus on evaluating medication use quality.
Dave Hachey, PharmD, is one of PQA’s expert faculty for the new 3-hour continuing education course, Measuring Quality to Improve HIV Medication Use. Hachey is a Professor of Family Medicine at Idaho State University. He has more than 20 years of experience in the fields of HIV and family medicine, as well as more than 10 years of experience in hepatitis C management. In addition to discussing treatment and prevention modalities, Hachey outlines key indicators for the successful treatment of HIV
The PQA Quality Forum Webinar is a regular, recurring series on healthcare quality topics with a focus on medication use and medication services. It is a forum for educating and engaging with PQA members and quality-focused healthcare professionals.
PQA offers a competitive Advanced Pharmacy Practice Experiential (APPE) Rotation for pharmacy students, which provides experiential learning opportunities in non-profit association management, medication use quality education, communications, research and performance measurement. PQA works with individual students to align their rotation experience with desired career goals and interests. Applications for the 2022-23 year are now being accepted. You can apply here. Visit our Student Programs page for more information.
PQA’s Board of Directors represents a diverse group of thought leaders and experts in healthcare, who understand how medication optimization improves patient outcomes and supports a value-based care system. Their expertise helps PQA advance the safe and appropriate use of medicines. This blog is one in a series profiling PQA's Board members.
